Ameritas Investment Partners, Inc.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1055980
LINCOLN, NE
Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,116,136
+$680,396 QoQ
Shares Held
18,489
0.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#258
of 768 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ameritas Investment Partners, Inc. holds $18,421,025 across 38 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
7,812 | $4,232,775 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
18,489 | $3,116,136 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
91,918 | $2,262,101 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
58,617 | $2,032,251 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
17,912 | $1,987,157 | |
| 6 | ALKS |
Alkermes plc.
|
15,222 | $797,632 | |
| 7 | LQDA |
Liquidia Corp
|
6,406 | $510,750 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
10,887 | $446,693 |
All Filings in NBIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,116,136 | 18,489 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $2,435,740 | 18,489 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $2,591,659 | 18,273 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $2,609,944 | 18,592 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $2,415,133 | 19,215 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $2,169,640 | 19,617 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $2,768,083 | 20,279 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $2,386,897 | 20,716 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $2,946,826 | 21,405 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $3,026,378 | 21,943 | Shares | Other | 2024-05-13 | |
| 2023-12-31 | $2,858,401 | 21,694 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $2,463,862 | 21,901 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $2,297,808 | 24,367 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $2,488,999 | 24,590 | Shares | Other | 2023-05-10 | |
| 2022-12-31 | $2,971,667 | 24,880 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $2,612,341 | 24,596 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $2,472,580 | 25,365 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $2,377,968 | 25,365 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $2,160,337 | 25,365 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $2,404,559 | 25,071 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $2,487,012 | 25,555 | Shares | Other | 2021-08-06 | |
| 2021-03-31 | $2,509,050 | 25,800 | Shares | Other | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||